Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients with mCRPCInitiating ...

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning ...

As consumers increasingly demand more features in smaller devices, the need for compact components like this MCU has become ...

The past month has been a bit of a whirlwind as I've made my way through various fashion weeks from London to Milan and ...

Some early users were enthusiastic about the product’s capabilities; others complained it took too long and crashed.

About Myris Therapeutics Myris Therapeutics is a privately held life sciences biotech company with proprietary technology to enable ultra-high DAR ADCs by integrating traditional ADC engineering with ...

Cutting corners: The software engineering job market has experienced a significant downturn, with job openings hitting a five-year low, according to an analysis of data from Indeed by Practical ...

A new report from The Atlantic has described Elon Musk’s DOGE access to immense amounts of government data as being in “god mode”. Tim O’Brien, MSNBC political analyst and senior executive ...

Myris, formerly known as BioHybrid Solutions, has built on its history in enzyme bioconjugate development to emerge as a new Antibody Drug Conjugate (ADC) therapeutics company focused on the ...